Nanjing Gaoke Company Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Public

  • Employees
  • 620

Employees

  • Stock Symbol
  • 600064

Stock Symbol

  • Investments
  • 24

  • Share Price
  • $1.11
  • (As of Friday Closing)

Nanjing Gaoke Company General Information

Description

Nanjing Gaoke Co Ltd is a China-based company engaged in real estate and municipal businesses, medical health business, and equity investment business. Its real estate business includes residential development, commercial operations, and property management, among others. Its medical health business includes the research and development, manufacture and sales of pharmaceuticals.

Contact Information

Website
www.600064.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Building A, Gaoke Center
  • No. 8 Xuejin Road, Qixia District
  • Nanjing, Jiangsu 210023
  • China
+86 025
Primary Industry
Private Equity
Other Industries
Infrastructure
Stock Exchange
SHG
Corporate Office
  • Building A, Gaoke Center
  • No. 8 Xuejin Road, Qixia District
  • Nanjing, Jiangsu 210023
  • China
+86 025

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanjing Gaoke Company Stock Performance

As of 13-Nov-2026, Nanjing Gaoke Company’s stock price is $1.11. Its current market cap is $1.93B with 1.73B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.11 $1.13 $1.04 - $1.33 $1.93B 1.73B 16.3M $0.10

Nanjing Gaoke Company Financials Summary

As of 30-Sep-2026, Nanjing Gaoke Company has a trailing 12-month revenue of $434M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 3,171,237 3,472,908 2,908,037 2,064,067
Revenue 433,505 475,325 275,976 668,992
EBITDA 172,867 277,242 252,662 237,351
Net Income 166,161 254,505 240,435 220,519
Total Assets 5,892,405 5,503,184 5,259,524 5,259,597
Total Debt 1,356,996 1,405,440 1,158,612 1,113,308
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nanjing Gaoke Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanjing Gaoke Company Investments (24)

Nanjing Gaoke Company’s most recent deal was a Early Stage VC with Ruichu. The deal was made on 07-Aug-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ruichu 07-Aug-2024 Early Stage VC Drug Discovery
Fuxinli New Materials 19-Jul-2024 Early Stage VC Specialty Chemicals
Lingpao 11-Jul-2024 Early Stage VC Application Specific Semiconductors
Xinke Semiconductor 30-May-2023 Early Stage VC Application Specific Semiconductors
Anhui ArgoSun 17-May-2023 Later Stage VC Other Semiconductors
You’re viewing 5 of 24 investments. Get the full list »

Nanjing Gaoke Company ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

30.99 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Real Estate

Industry

of 904

Rank

Percentile

Real Estate Development

Subindustry

of 196

Rank

Percentile

To view Nanjing Gaoke Company’s complete esg history, request access »

Nanjing Gaoke Company Exits (5)

Nanjing Gaoke Company’s most recent exit was on 27-Mar-2020 from Vazyme Biotech. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Vazyme Biotech 27-Mar-2020 Completed
  • 2 buyers
Allist Pharmaceuticals 23-May-2019 Completed
  • 8 buyers
HanSight 26-Jul-2017 Completed
  • 4 buyers
ACROBiosystems 20-Apr-2017 Completed
  • 2 buyers
HanSight 01-Jun-2016 Early Stage VC Completed
  • 3 buyers
To view Nanjing Gaoke Company’s complete exits history, request access »

Nanjing Gaoke Company FAQs

  • When was Nanjing Gaoke Company founded?

    Nanjing Gaoke Company was founded in 1992.

  • Where is Nanjing Gaoke Company headquartered?

    Nanjing Gaoke Company is headquartered in Nanjing, China.

  • What is the size of Nanjing Gaoke Company?

    Nanjing Gaoke Company has 620 total employees.

  • What industry is Nanjing Gaoke Company in?

    Nanjing Gaoke Company’s primary industry is Private Equity.

  • Is Nanjing Gaoke Company a private or public company?

    Nanjing Gaoke Company is a Public company.

  • What is Nanjing Gaoke Company’s stock symbol?

    The ticker symbol for Nanjing Gaoke Company is 600064.

  • What is the current stock price of Nanjing Gaoke Company?

    As of 13-Nov-2026 the stock price of Nanjing Gaoke Company is $1.11.

  • What is the current market cap of Nanjing Gaoke Company?

    The current market capitalization of Nanjing Gaoke Company is $1.93B.

  • What is Nanjing Gaoke Company’s current revenue?

    The trailing twelve month revenue for Nanjing Gaoke Company is $434M.

  • What is Nanjing Gaoke Company’s annual earnings per share (EPS)?

    Nanjing Gaoke Company’s EPS for 12 months was $0.10.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process